{"id":"NCT01709903","sponsor":"Novartis Pharmaceuticals","briefTitle":"A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149","officialTitle":"A 26-week Treatment Randomized, Double-blind, Double Dummy, Parallel-group Study to Assess the Efficacy and Safety of QVA149 (Indacaterol / Glycopyrronium Bromide) Compared to Fluticasone/Salmeterol in Patients With Moderate to Severe COPD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-11","primaryCompletion":"2014-02","completion":"2014-02","firstPosted":"2012-10-18","resultsPosted":"2015-03-17","lastUpdate":"2015-03-17"},"enrollment":744,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"QVA149","otherNames":["Experimental: QVA149"]},{"type":"DRUG","name":"Fluticasone/salmeterol","otherNames":["Comparator: Fluticasone/salmeterol"]},{"type":"DRUG","name":"Placebo to QVA149","otherNames":["Experimental: QVA149"]},{"type":"DRUG","name":"Placebo to fluticasone/salmeterol","otherNames":["Comparator: fluticasone/salmeterol"]}],"arms":[{"label":"QVA149","type":"EXPERIMENTAL"},{"label":"fluticasone/salmeterol","type":"ACTIVE_COMPARATOR"}],"summary":"To demonstrate the non-inferiority of QVA149 110/50 µg o.d. to fluticasone/salmeterol 500/50 µg b.i.d. in terms of trough Forced Expiratory Volume in one second (FEV1) (mean of 23 hours 15 min and 23 hours 45 min post QVA149 dose) following 26 weeks of treatment in patients with moderate to severe COPD","primaryOutcome":{"measure":"Trough Forced Expiratory Volume in One Second (FEV1) Following 26 Weeks of Treatment to Demonstrate the Non-inferiority of QVA149 110/50 μg o.d. to Fluticasone/Salmeterol 500/50 μg b.i.d","timeFrame":"26 weeks","effectByArm":[{"arm":"QVA149","deltaMin":1.248,"sd":0.0173},{"arm":"Fluticasone/Salmeterol","deltaMin":1.176,"sd":0.0172}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":55,"countries":["Argentina","Chile","China","Taiwan"]},"refs":{"pmids":["27715335","26082625"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":372},"commonTop":["Chronic obstructive pulmonary disease","Nasopharyngitis","Upper respiratory tract infection","Bronchitis","Pyrexia"]}}